|
|
|
|
Report No. : |
511336 |
|
Report Date : |
30.05.2018 |
IDENTIFICATION DETAILS
|
Name : |
OOO
MIRACLE PHARM |
|
|
|
|
Registered Office : |
Logisticheskaya (Severniy Mkr.) Street 1/6, Moscow Region,
142000 Domodedova |
|
|
|
|
Country : |
Russia |
|
|
|
|
Financials (as on) : |
31.12.2016 |
|
|
|
|
Date of Incorporation : |
20.11.2013 |
|
|
|
|
Com. Reg. No.: |
OGRN 5137746100487 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Wholesale of pharmaceutical goods |
|
|
|
|
No. of Employees : |
20 |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with moderate
risk of default |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Slow but Correct |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
Russia |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
RUSSIA - ECONOMIC
OVERVIEW
Russia has undergone significant changes since the collapse of the Soviet Union, moving from a centrally planned economy towards a more market-based system. Both economic growth and reform have stalled in recent years, however, and Russia remains a predominantly statist economy with a high concentration of wealth in officials' hands. Economic reforms in the 1990s privatized most industry, with notable exceptions in the energy, transportation, banking, and defense-related sectors. The protection of property rights is still weak, and the state continues to interfere in the free operation of the private sector.
Russia is one of the world's leading producers of oil and natural gas, and is also a top exporter of metals such as steel and primary aluminum. Russia is heavily dependent on the movement of world commodity prices as reliance on commodity exports makes it vulnerable to boom and bust cycles that follow the volatile swings in global prices. The economy, which had averaged 7% growth during the 1998-2008 period as oil prices rose rapidly, has seen diminishing growth rates since then due to the exhaustion of Russia’s commodity-based growth model.
A combination of falling oil prices, international sanctions, and structural limitations pushed Russia into a deep recession in 2015, with GDP falling by close by 2.8%. The downturn continued through 2016, with GDP contracting another 0.2%, but was reversed in 2017 as world demand picked up. Government support for import substitution has increased recently in an effort to diversify the economy away from extractive industries.
|
Source
: CIA |
|
COMPANY NAME |
OOO MIRACLE PHARM |
|||||||
|
|
||||||||
|
ADDRESS |
Building |
Street |
Area |
PO Box |
||||
|
N/A |
Logisticheskaya (Severniy Mkr.) Street 1/6 |
Moscow Region |
142000 Domodedova |
|||||
|
TEL/FAX |
Verified Phones: (+7 495) 984 7579 / Fax: (+7 495) 984 7579 |
|||||||
|
EMAIL/WEBSITE |
Email: a.zhukova@ncpharm.ru / Website: N/A |
|||||||
|
ACTIVITY |
NACE 4646 - Wholesale of pharmaceutical goods; |
|||||||
|
PRINCIPAL |
Eduard
Nikolaevich Savin |
Workforce |
||||||
|
Managing Director |
20 |
|||||||
|
LEGAL INFO |
Date Of Est. |
Reg. No. |
Legal Form |
Status |
||||
|
20/11/2013 |
OGRN
5137746100487 |
LLC |
Active |
|||||
|
CAPITAL |
CURRENCY |
AMOUNT |
||||||
|
RUBLE (RUB) |
3,000,000 |
|||||||
IDENTIFICATION |
|||
|
CO. NAME |
OOO
MIRACLE PHARM |
||
|
ENQUIRED NAME |
MIRACLE PHARM LLC |
||
|
ALSO KNOWN NAME (S) |
OOO Mirakl Farm / MIRACLE PHARM LLC |
||
|
STREET |
Logisticheskaya
(Severniy Mkr.) Street 1/6 |
||
|
AREA |
Moscow Region |
||
|
POSTAL ADDRESS |
142000 Domodedova |
||
|
CITY |
Domodedova |
||
|
COUNTRY |
Russia |
||
|
TELEPHONE |
(+7 495) 984 7579 |
||
|
FAX |
(+7 495) 984 7579 |
||
|
VERIFIED EMAIL |
a.zhukova@ncpharm.ru |
||
|
BUSINESS HOURS |
DAYS |
OFFICE HOURS |
BREAK TIME |
|
Mon-Fri |
09:00-18:00 |
13:00-14:00 |
|
|
REGISTERED ADDRESS |
Logisticheskaya
(Severniy Mkr.) Street 1/6, Moscow Region, 142000 Domodedova, Russia |
||
|
ADDITIONAL OFFICE |
Mira Avenue 13, Office 215, Moscow 129090, Russia. |
||
SENIOR PERSONNEL |
||
|
MANAGEMENT |
NAME |
POSITION |
|
Eduard Nikolaevich Savin Nationality: Russian Tax Code: INN 772138670100 |
Managing Director |
|
|
Anastasiya Zhukova |
Chief Accountant |
|
|
WORKFORCE |
NO. OF EMPLOYEES |
PERIOD |
|
20 |
05.2018 |
|
FINANCIAL SUMMARY |
||
|
REVENUE |
31/12/2017 (approx) |
31/12/2016 |
|
RUBLE 1,200,000,000 |
RUBLE 885,614,000 |
|
|
NET PROFIT / (LOSS) |
31/12/2016 |
31/12/2015 |
|
RUBLE 143,055,000 |
RUBLE (2,447,000) |
|
|
PROFIT BEFORE TAX |
RUBLE 178,835,000 as of 31/12/2016 |
|
|
STOCK/INVENTORIES |
RUBLE 197,513,000 as of 31/12/2016 |
|
|
FISCAL YEAR-END |
31 December. |
|
LEGAL STATUS |
||
|
INCORPORATION |
20/11/2013 |
|
|
REGISTRATION NO. |
C.R. NUMBER |
ISSUED BY |
|
OGRN
5137746100487 |
Federal Tax Service |
|
|
OTHER REGISTRATION
NO. |
INN 7727819846 (Tax Code) /
KPP 500901001 / OKPO 20658919 (Statistics Code) / OKTMO 46709000001 |
|
|
AUTHORISED CAPITAL |
AMOUNT |
CURRENCY |
|
3,000,000 |
RUBLE |
|
|
PAID-UP CAPITAL |
AMOUNT |
CURRENCY |
|
3,000,000 |
RUBLE |
|
|
BUSINESS HISTORY |
The Company was incorporated in Russia on 20 November 2013. |
|
|
LEGAL FORM |
Limited Liability Company |
|
|
STATUS |
Active |
|
|
SHAREHOLDERS |
NAME |
PERCENTAGE |
|
Aleksandr Markovich Malinkovich Nationality: Russian Tax Code: INN 771410096911 |
100.00% |
|
OPERATION |
|
|
BANKERS |
AO Alfa-Bank Kalanchevskaya Street 27 Moscow 107078 Russia Telephone: (+7 495) 620
9191 SWIFT: ALFARUMM |
|
ACTIVITY CODE
(NACE) |
4646 - Wholesale of
pharmaceutical goods; |
|
LINE OF BUSINESS |
Trading as importers, distributors and wholesalers of pharmaceutical
products as well as pharmaceutical substances used for manufacturing of
domestic drug products: antibiotics, products for ulcers and cardiovascular
diseases, and vitamins. Subject closely cooperates with: OOO NC Pharm Logisticheskaya
(Severniy Mkr.) Street 1/6, Moscow Region 142000 Domodedova Russia Est.: 11/07/2001 Managing Director:
Garold Vlasov C.R. No.: OGRN
1037700144272 Tax Code: INN 7710384474 |
|
IMPORT FROM |
Europe, USA, China and India. |
|
EXPORT TO |
Subject does not engage in exporting activities. |
|
TRADE REFERENCES |
1. OAO AVVA RUS Krylatskie Kholmy Street 30/9 Moscow 121614 Russia 2. OAO Biokhimik Vasenko Street 15a Saransk Republic of Mordovia Russia |
|
FACILITIES |
Premises comprising administrative offices located at the heading
address as well as additional offices located at Mira Avenue 13, Office 215,
Moscow 129090, Russia. |
|
RELATED COMPANIES |
Associates 1. OOO IMPEX Polevaya Street 1a/4 Smolenskiy District vllage Pechersk Smolensk Region Est.: 06/04/2010 C.R. No.: OGRN 1106731003059 Tax Code: INN 6731080330 Sole Shareholder: Aleksandr Markovich
Malinkovich 2. OOO Solo Film Studiya Aviamotornaya Street 50/2 Moscow 111024 Est.: 09/02/2017 C.R. No.: OGRN 1177746125864 Tax Code: INN 7722389981 Sole Shareholder: Aleksandr Markovich
Malinkovich 3. OOO AVTOPROM SERVIS Staroobryadcheskaya Street
28a/1 Moscow 111024 Est.: 11/02/2016 C.R. No.: OGRN 1167746150494 Tax Code: INN 7722354805 Shareholders: Aleksey Tarasov – 33.4% Aleksandr Markovich
Malinkovich – 33.3% Denis Frolov – 33.3% |
FINANCIAL INFORMATION |
|
|
CURRENCY |
RUBLE |
|
NOTES |
Balance sheets as at
31 December 2016 showed : 31/12/2016 31/12/2015 (in RUBLE) ASSETS Total non-current assets 0 0 Current assets Stock 197,513,000 126,000 Value added tax on purchased
valuables 8,855,000 0 Trade receivables 349,895,000 309,000 Financial investments 3,465,000 0 Cash equivalents 32,255,000 163,000 Other currents
assets 49,000 0 Total current assets 592,033,000 598,000 TOTAL ASSETS 592,033,000 598,000 EQUITY &
LIABILITIES Total Equity 140,105,000 (2,951,000) Total long-term liabilities 0 0 Short-term liabilities Borrowings 2,923,000 2,651,000 Accounts payable 449,004,000 898,000 Total Short-term Liabilities 451,927,000 3,549,000 TOTAL EQUITY & LIABILITIES 592,033,000 598,000 INCOME STATEMENT Revenue 885,614,000 1,939,000 Cost of Sales (679,348,000) (3,484,000) Gross Profit 206,266,000 (1,545,000) Administrative expenses (22,968,000) 0 Profit(loss) from sales 183,298,000 (1,545,000) Other income and
expenses Interest income 125,000 0 Interest payable (272,000) 0 Other income 82,071,000 0 Other expenses (86,387,000) (899,000) Profit(loss) before taxation 178,835,000 (2,444,000) Current income tax
(35,780,000) (3,000) Net Profit(loss) 143,055,000 (2,447,000) |
SPECIAL REMARKS |
|
|
INTERVIEWED |
Anastasiya Zhukova
(Chief Accountant). |
|
COMMENTS |
You enquired on: MIRACLE
PHARM LLC. Please note that this name applies to an English translation of
the subject’s name. Subject’s correct registered name is as per heading. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 67.82 |
|
|
1 |
INR 90.17 |
|
Euro |
1 |
INR 78.70 |
|
RUB |
1 |
INR 1.08 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
NIY |
|
|
|
|
Report Prepared
by : |
TRU |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.